Prometheus Laboratories Announces the Launch of PredictrPK ADA, A Precision-Guided Dosing Test for Optimization of Adalimumab

2 years ago

PredictrPK® ADA addresses the unmet need for individualized optimization of adalimumab (ADA) therapy in support of sustained clinical remission and…

In Honor of World Nature Conservation Day, Jaguar Health Announces Planting of More Than 1.1 Million Trees in Peruvian Amazon

2 years ago

Activities support sustainable supply of Jaguar's botanical drug crofelemer, the active ingredient in the company's FDA-approved human drug Mytesi® and…

Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings

2 years ago

ORLANDO, FL / ACCESSWIRE / July 27, 2023 / Nutriband Inc. (the "Company") (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products,…

Ortho Dermatologics Announces 2023 Aspire Higher Scholarship Recipients

2 years ago

Scholarships Awarded to Six Students Affected by Dermatologic ConditionsLAVAL, QC / ACCESSWIRE / July 27, 2023 / Bausch Health Companies…

NeoGenomics Announces Medicare Coverage for RaDaR Assay for Minimal Residual Disease and Recurrence in Breast Cancer

2 years ago

FT. MYERS, FL / ACCESSWIRE / July 27, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, announced…

Asensus Surgical Announces $10 Million Registered Direct Offering

2 years ago

RESEARCH TRIANGLE PARK, N.C., July 27, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) (“Asensus” or the “Company”),…

NABP Collaborates With IBM to Build New Digital Platform to Protect the Drug Supply Chain

2 years ago

Pulse by NABP™ to connect the full supply chain that provides safe medication to patients in the United States |…

Editas Medicine and Azzur Group Expand Partnership to Accelerate Editas’ Manufacturing Capabilities for Advancing the EDIT-301 Program Through Approval to Commercialization

2 years ago

CAMBRIDGE, Mass., and DEVENS, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing…

Disc Medicine Announces First Patient Enrolled in Phase 1/2 Clinical Trial of Bitopertin in Diamond-Blackfan Anemia (DBA)

2 years ago

WATERTOWN, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery,…

Celularity and Verséa Ophthalmics Announce Exclusive U.S. Commercialization Agreement to Distribute Biovance® and Biovance® 3l Ocular For Ophthalmic Applications

2 years ago

FLORHAM PARK, N.J. and TAMPA, Fla., July 27, 2023 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a biotechnology company…